However, because the product has not been tested in clinical trials, the complete side effect profile is unknown
Microdosing titration with smaller dose increments Strategy B: Increase dosing frequency with reduced dose size This method involves administering smaller doses more frequently than once per week (e.g., every 34 days), which can help maintain more stable drug levels and potentially reduce side effects caused by peak concentrations
Who Should Consider Prescription GLP-1 Options Over OTC Alternatives Individuals with BMI over 27, metabolic syndrome, prediabetes, or type 2 diabetes have the strongest clinical evidence supporting prescription GLP-1 therapy
ReShape Lifesciences (RSLS) noted that GLP-1s have reduced initial consultations for its LAP-BAND Surgery. LastBearStanding on Substack Teleflex Incorporated, Q2 2023 Earnings Call, Aug 03, 2023: We continue to monitor the usage of GLP-1 drugs in treating obesity